Home›Search›Neurodegenerative Disease Management

Neurodegenerative Disease Management

Taylor and Francis Ltd. · United Kingdom · Est. 1974

ISSN1758-2024eISSN1758-2032

SJR Q2✓ WOS ESCI✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Scopus Q266

✓ Corroboration (3 more)+18

Total84

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

135

days submission → published

measured · last 19 articles · accept 111d

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.804

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.728

Total Worksi

852

Total Citationsi

10,482

2yr Mean Citednessi

1.38

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Neurodegenerative Disease Management presents findings, analysis, and commentary on neurodegenerative diseases. The journal provides guidance to the multidisciplinary disease management community regarding effective treatment strategies, emerging research, and multidisciplinary approaches, covering topics from disease mechanisms.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1974

FrequencySix No. A Year

StatusActive (last: 2026)

Total Publications852

Publisher OrgFuture Medicine

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1758-2024 / 1758-2032

✅

Indexed in a trusted database?

WoS, Scopus, PubMed

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

530

2019

825

2020

508

2021

476

2022

157

2023

141

2024

104

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Q2

Neurology (clinical)Q2

Subject Classification

Web of Science Categories

Clinical Neurology

Scopus Categories

Neurology (clinical)Medicine (miscellaneous)

Research Topics (OpenAlex)

Parkinson's Disease Mechanisms and TreatmentsMultiple Sclerosis Research StudiesDementia and Cognitive Impairment ResearchNeurological disorders and treatmentsAlzheimer's disease research and treatmentsAmyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative DiseasesPeripheral Neuropathies and DisordersCholinesterase and Neurodegenerative DiseasesNeurogenetic and Muscular Disorders Research

Frequently asked questions about Neurodegenerative Disease Management

Is Neurodegenerative Disease Management a predatory journal?

PubScope has no integrity flags on record for Neurodegenerative Disease Management: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 84/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Neurodegenerative Disease Management?

Neurodegenerative Disease Management is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.38.

Is Neurodegenerative Disease Management indexed in Scopus and Web of Science?

Neurodegenerative Disease Management is indexed in Web of Science, Scopus.